Mrv1909 11162223202D 22 23 0 0 0 0 999 V2000 -5.0013 2.8875 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0 -4.2868 3.3000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -3.8743 2.5855 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0 -4.6993 4.0145 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0 -3.5724 3.7125 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 -2.8579 3.3000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -2.1434 3.7125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.4289 3.3000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.4289 2.4750 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.7145 2.0625 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 0.0000 2.4750 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 0.0000 3.3000 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 0.7145 2.0625 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 1.4289 2.4750 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.4289 3.3000 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 2.1434 2.0625 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 2.8971 2.3981 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 3.4491 1.7850 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 3.0366 1.0705 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 2.2296 1.2420 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -2.1434 2.0625 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -2.8579 2.4750 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1 2 1 0 0 0 0 2 3 1 0 0 0 0 2 4 1 0 0 0 0 2 5 1 0 0 0 0 5 6 1 0 0 0 0 6 7 2 0 0 0 0 7 8 1 0 0 0 0 8 9 2 0 0 0 0 9 10 1 0 0 0 0 10 11 1 0 0 0 0 11 12 2 0 0 0 0 11 13 1 0 0 0 0 13 14 1 0 0 0 0 14 15 2 0 0 0 0 14 16 1 0 0 0 0 16 17 1 0 0 0 0 17 18 1 0 0 0 0 18 19 1 0 0 0 0 19 20 1 0 0 0 0 16 20 1 0 0 0 0 9 21 1 0 0 0 0 21 22 2 0 0 0 0 6 22 1 0 0 0 0 M END > DB17121 > drugbank > FC(F)(F)OC1=CC=C(NC(=N)NC(=N)N2CCCC2)C=C1 > InChI=1S/C13H16F3N5O/c14-13(15,16)22-10-5-3-9(4-6-10)19-11(17)20-12(18)21-7-1-2-8-21/h3-6H,1-2,7-8H2,(H4,17,18,19,20) > NGFUHJWVBKTNOE-UHFFFAOYSA-N > C13H16F3N5O > 315.3 > 315.130694644 > 6 > 38 > 1.9177342334046432 > 29.460599226948858 > 1 > 4 > 0 > 1 > N'-(pyrrolidine-1-carboximidoyl)-N-[4-(trifluoromethoxy)phenyl]guanidine > 2.26 > 3.102557632666666 > -3.97 > 0 > 2 > 2 > 2 > 10.16928085593577 > 84.23 > 93.58699999999999 > 3 > 1 > 3.35e-02 g/l > N'-cyclopropyl-N-{3-[5-(morpholin-4-ylmethyl)-1H-1,3-benzodiazol-2-yl]-1H-pyrazol-4-yl}carbamimidic acid > 0 > DB17121 > investigational > IM-156 free base > 1-pyrrolidinecarboximidamide, n-(imino((4-(trifluoromethoxy)phenyl)amino)methyl)-; Hl-156a free base; Hl156a free base; Im156 free base; N-(imino((4-(trifluoromethoxy)phenyl)amino)methyl)-1-pyrrolidinecarboximidamide > IM-156 $$$$